Eric Dietrich, Pharm.D.,; Petitioner seeks to clarify whether the clinical activities as described in the petition, including ordering and interpreting laboratory results, executing drug therapy orders which may include starting, stopping or ...  

  •  

    DEPARTMENT OF HEALTH

    Board of Pharmacy

    RULE NO.:RULE TITLE:

    64B16-27.830:Standards of Practice - Drug Therapy Management

    NOTICE IS HEREBY GIVEN that the Board of Pharmacy has received the petition for declaratory statement from Eric Dietrich, Pharm.D., The petition seeks the agency's opinion as to the applicability of subsection 64B16-27.830(1), F.A.C., as it applies to the petitioner.

    Petitioner seeks to clarify whether the clinical activities as described in the petition, including ordering and interpreting laboratory results, executing drug therapy orders which may include starting, stopping or adjusting medication doses, and providing clinical services in the outpatient setting, when performed under the direct supervision of a physician for an established patient in accordance with a Prescriber Care Plan signed by a physician that is in compliance with the rule, are within the scope of practice for a licensed Florida pharmacist. Except for good cause shown, motions for leave to intervene must be filed within 21 days after the publication of this notice.

    A copy of the Petition for Declaratory Statement may be obtained by contacting: C. Erica White, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254or by email at info@floridaspharmacy.gov within 14 days of publication of this notice.

Document Information

Meeting:
Rule 64B16-27.830(1), F.A.C.,
Contact:
C. Erica White, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254or by email at info@floridaspharmacy.gov within 14 days of publication of this notice.
Related Rules: (1)
64B16-27.830. Standards of Practice - Drug Therapy Management